SEC Form 4 · accession 0001437749-18-006183
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack B. Strommen
Director
Period of report
Mar 31, 2018
Accepted (ET)
Apr 3, 2018 · 2:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1,F2 | $0.259 | Mar 31, 2018 | A | 57,916 | A | Mar 31, 2018 | Mar 31, 2028 | Common stock | 57,916 | 140,054 | D |
Explanation of responses
- F1This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors pursuant to a plan adopted by the Issuer's Board to retire outstanding accounts payable.
- F2Reported number does not include warrants to purchase 3,590,476 shares of Issuer's common stock.